Quantum Dots: Theory and Applications

Cover
Quantum Dots: Theory and Applications
©
Contents
Preface
Chapter 1 Theory of Excitons and Excitonic Quasimolecules Formed from Spatially Separated Electrons and Holes in Quasi-Zero-Dimensional Nanostructures
	1. Introduction
	2. Spectroscopy of excitons in Quasi - Zero - Dimensional nanosystems
	3. Excitonic quasimolecules formed from spatially separated electrons and holes
	4. Theory of new superatoms — Analogue atoms from the group of alkali metals
	5. Conclusions
	Author details
	References
Chapter 2 Excitons and Trions in Semiconductor Quantum Dots
	1. Introduction
	2. Theoretical model
		2.1. Exciton
		2.2. Negative trion
		2.3. Positive trion
	3. Results and discussion
	4. Conclusion
	5. Appendix
	Author details
	References
Chapter 3 On the ’Three-Orders Time-Limit’ for Phase Decoherence in Quantum Dots
Chapter 4 Charge States in Andreev Quantum Dots
Chapter 5 Quantum Dots Prepared by Droplet Epitaxial Method
	1. Introduction
	2. The droplet epitaxial technique
		2.1. Technological background and preliminaries of the droplet epitaxial technique
		2.2. Principles of DE
		2.3. QD engineering
	3. Droplet formation
		3.1. The initial surface status
		3.2. Size and density of the droplets
		3.3. Droplet–surface interaction
	4. Formation of QD
		4.1. Preparation technology
		4.2. Geometry and electronic structure of QD
		4.3. Some aspects to the kinetics of QD growth
	5. Ringlike QD preparation
		5.1. Growth technology of ringlike QD
		5.2. Geometry and electronic structure of the ringlike QD
		5.3. Some aspects to the formation of ringlike nanostructure
	6. Specular-shaped QDs and complexes
		6.1. The inverted QDs
		6.2. The laterally aligned QD pairs
		6.3. Configuration of QD ensembles
	Author details
	References
Chapter 6 Physical Reasons of Emission Varying in CdSe/ZnS and CdSeTe/ZnS Quantum Dots at Bioconjugation to Antibodies
	1. Introduction
	2. QD bioconjugation process and experimental details
	3. The bioconjugation study of CdSe/ZnS QDs
		3.1. CdSe/ZnS QDs bioconjugated to anti-IL-10 Ab
		3.2. CdSe/ZnS QDs bioconjugated to HPV E7 and PRV Ab
	4. Discussion of the CdSe/ZnS QD bioconjugation
	5. The bioconjugation study of CdSeTe/ZnS QDs
		5.1. CdSeTe/ZnS QDs bioconjugated to anti-IL-10 Ab
		5.2. CdSeTe/ZnS QDs bioconjugated to the HPV and PRV antibodies
	6. Discussion of the CdSeTe/ZnS QD bioconjugation
	7. Conclusion
	Author details
	References